Our results propose a mechanism for leptin delivery via EVs, offering a significant advancement in understanding how EVs released by obese AT act in promoting breast cancer malignancy and providing new insights into the interplay between obesity, leptin signaling, and tumor progression. The gene discussed is LEP; the disease is breast cancer.